Clinical trial record for JOGO EMG biofeedback in chronic low-back pain, migraine, and persistent post-mastectomy/lumpectomy pain; useful as cancer pain/rehab source trail.
Biofeedback
Device-assisted mind-body training that helps patients observe and regulate heart rate, breathing, muscle tension, brainwave patterns, skin conductance, or other physiologic signals; in cancer care it is mainly supportive for stress, anxiety, pain, CIPN, sleep, fatigue, menopausal symptoms, and quality of life. Biofeedback uses sensors and real-time visual, auditory.
Three-arm longitudinal RCT testing remote smartphone HRV biofeedback in breast cancer survivors; active HRV biofeedback improved menopausal symptoms and psychological well-being compared with controls.
NCI overview explaining that cancer patients may use CAM to cope with treatment side effects, comfort themselves, or try to treat cancer, and that CAM should be discussed with the care team. Used to frame grounding as supportive rather than curative.
General clinical overview of biofeedback types and uses, including EMG, EEG/neurofeedback, heart-rate variability, temperature, and skin-conductance feedback.
General medical overview of biofeedback using sensors to monitor body functions and train changes for conditions including pain and stress.
Scoping review of HRV biofeedback in cancer patients, examining autonomic balance, symptom management, distress, sleep, pain, fatigue, anxiety, depression, and quality of life; concludes evidence is heterogeneous but suggests symptom and well-being improvement.
Randomized trial of behavioral interventions for anticipatory nausea and vomiting during chemotherapy; included as behavioral symptom-management context adjacent to biofeedback and relaxation training.
RCT of wearable EEG meditation feedback in newly diagnosed breast cancer patients; feasible with improvement over time in fatigue, stress, and QOL in both groups, but no significant between-group differences.
Randomized clinical trial comparing anxiety-regulation group interventions in early breast cancer survivorship; included for psycho-oncology/biofeedback-adjacent anxiety-regulation context.
MD Anderson randomized pilot trial: neurofeedback group improved CIPN symptoms versus waitlist control, with EEG changes predictive of symptom reduction.
Commercial page for the Elysium Device using biofeedback, light/sound/air/earth/quantum energies, AI, and broad wellness claims; useful as proponent marketing source trail.
Commercial site using quantum field, photonic light, AI biofeedback, cellular regeneration, and future healing language.